Topics

Articles

But the global picture is sunny as most of the global market growth benefits the generic makers

Generics Manufacturers Grapple With Tight Economics

Even as diagnosed (and “prediabetes”) cases rise worldwide, healthcare providers struggle with patients to control the course of the disease. New therapies—and new health services—are aiding in the battle

THE ONGOING DIABETES BATTLEGROUND

Trends in site selection, regional economic development and business expansion

For a Lucky Few, Biopharma Expansion a Reality Again

A looming crisis in drug-resistant anti-infectives is not being met with a commensurate industry effort. Governments and industry are trying to cope

The Struggle to Get Anti-Infectives on a Faster Track to Commercialization

As hundreds of candidate drugs receive official “orphan” status, the Orphan Drug Act gets re-examined. Meanwhile, these drugs are driving the growth of specialty pharmacy

Rare Diseases and Orphan Drugs Lift Pharma Innovation

The 2010 PDMA Sharing Conference: Expanding Our Focus With More Learning Opportunities

PDMA 2010: The Power of Sharing

Industry’s coming challenges will force dramatic change on how products are brought to market and businesses are sustained. Industry leaders have already started the process

The Drive to Develop New Commercial Models

Faced with fierce competition, dwindling budgets and intense pressure to create jobs, economic development authorities are reinventing their recruitment strategies to attract life sciences employers

Brand & Product Security